Scynexis is a New Jersey-based biotechnology company that researches, develops, and commercializes novel anti-infective therapies for the treatment of fungal infections.
Business Model:
Revenue: $4.2M
Employees: 51-200
Address: 1 Evertrust Plaza
City: Jersey City
State: NJ
Zip: 07302
Country: US
Scynexis is a New Jersey-based biotechnology company that researches, develops, and commercializes novel anti-infective therapies for the treatment of fungal infections.
Contact Phone:
+12018845485
Contact Email:
Listed Exchange:
NASDAQ
IPO Date:
5/9/2014
IPO Valuation:
$84M
Ticker Symbol:
SCYX
IPO Price:
$10/share
Amount Raised:
$62M
Opened: -/share
EBITDA | - |
Total Cash | - |
Total Debt | - |
Total Revenue | - |
Total Profit (Gross) | - |
PE Ratio | - |
Announced Date | Company | Transaction | Money Raised |
---|
Announced Date | Transaction | Number of Investors | Money Raised | Lead Investors | 1/2016 | Debt Financing | 1 | $15M |
Armentum Partners Armentum Partners |
5/2021 | Post-IPO Debt | 2 | $60M |
Silicon Valley Bank Hercules Capital Hercules Capital Silicon Valley Bank Silicon Valley Bank Hercules Capital Hercules Capital Silicon Valley Bank |
10/2016 | Post-IPO Debt | $15M |
Solar Capital Ltd. |
4/2022 | Post-IPO Equity | $45M | 5/2014 | IPO | $62M | 12/2019 | Post-IPO Equity | $35M | 5/2021 | Post-IPO Debt | $20M |
Hercules Capital Silicon Valley Bank |
5/2012 | Venture Round | $11.4M | 12/2020 | Post-IPO Equity | $85M |
---|
Announced Date | Name | Price |
---|
|
Revenue: 0 - 100000 Employees: Industry: Software |
Details
|
|
Revenue: 0 - 100000 Employees: 51 - 500 Industry: Education |
Details
|
|
Revenue: 0 - 100000 Employees: 1 - 10 Industry: Blockchain |
Details
|
|
Revenue: 0 - 100000 Employees: 11 - 50 Industry: Industrial |
Details
|
|
Revenue: 0 - 100000 Employees: 1 - 10 Industry: Advertising |
Details
|